Clinical trials
Phase 1/2 Glioma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
141 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 3 |
| 2001 | 4 |
| 2002 | 3 |
| 2003 | 1 |
| 2005 | 5 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 6 |
| 2010 | 4 |
| 2011 | 9 |
| 2012 | 5 |
| 2013 | 5 |
| 2014 | 5 |
| 2015 | 11 |
| 2016 | 8 |
| 2017 | 4 |
| 2018 | 6 |
| 2019 | 3 |
| 2020 | 8 |
| 2021 | 5 |
| 2022 | 9 |
| 2023 | 3 |
| 2024 | 8 |
| 2025 | 7 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 65 |
| Recruiting | 21 |
| Terminated | 18 |
| Active, not recruiting | 10 |
| Unknown status | 9 |
| Withdrawn | 9 |
| Not yet recruiting | 5 |
| Suspended | 2 |
| Enrolling by invitation | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 8 |
| M.D. Anderson Cancer Center | 4 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 4 |
| Duke University | 3 |
| Fuda Cancer Hospital, Guangzhou | 3 |
| INSYS Therapeutics Inc | 3 |
| Boston Scientific Corporation | 2 |
| Celgene | 2 |
| Dana-Farber Cancer Institute | 2 |
| Eli Lilly and Company | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glioma | 141 |
| Glioblastoma | 73 |
| Brain Neoplasms | 53 |
| Astrocytoma | 37 |
| Central Nervous System Neoplasms | 24 |
| Oligodendroglioma | 24 |
| Gliosarcoma | 23 |
| Recurrence | 16 |
| Neoplasms | 13 |
| Medulloblastoma | 12 |
Trials
Showing 1 to 25 of 141. Each trial links to its page on Pharma Observatory.
41 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.